Flow cytometry markers: Key applications and insights

Flow cytometry markers are molecular indicators, typically surface or intracellular proteins, used to identify and characterize cell populations in research and clinical applications.

Flow cytometry, a laser-based technology widely used in scientific research and clinical diagnostics, utilizes specific markers to accurately and efficiently assess various cellular properties. These markers are vital for simultaneously measuring multiple parameters, including cell size, granularity, and the expression of specific proteins.

It has applications across multiple disciplines, such as immunology, oncology, molecular biology, and microbiology, playing an important role in diagnosing diseases, monitoring treatments, and advancing biological research. With ongoing advancements, flow cytometry markers continue to play a pivotal role in understanding complex cellular dynamics and enhancing precision medicine

What are flow cytometry markers?

Flow cytometry markers are specialized molecules used to identify and analyze specific cellular features in a heterogeneous population of cells. These markers, typically fluorescently labeled antibodies or dyes, bind to cellular components such as surface proteins, intracellular molecules, or nucleic acids.

Flow cytometry analyzes single cells or particles in a solution as they flow past lasers, measuring light scatter and fluorescence. Light scatter is measured by two optical detectors: forward scatter (FSC), which indicates cell size, and side scatter (SSC), which reflects internal complexity, both independent of fluorescence. Fluorescence is detected using dyes, fluorescent proteins, or antibody conjugates, enabling multi-parameter analysis of cellular properties.

Types of flow cytometry markers

Flow cytometry markers can be categorized into surface markers, intracellular markers, and functional markers. Each type plays a distinct role in the study of cellular biology and function.

Surface markers

Cell surface markers are molecules expressed on the plasma membrane, recognized by antibodies, which allow researchers to precisely identify and isolate specific cell types. These markers are particularly effective in classifying cells, especially within the hematopoietic lineage and are extensively used in research, diagnostics, and treatment. Key examples of surface markers include:

Cluster of differentiation (CD) markers: Cluster of differentiation markers, such as CD45RA, CD31, and CD62L, are used to identify naive T cells, while CD4 and CD8 identify T cell subsets, and CD19 and CD20 are commonly used for B cells.
Adhesion molecules: Integrins, selectins, and members of the immunoglobulin superfamily are vital for studying cell migration and interaction.
Receptors: Cytokine receptors (eg CD25, part of the IL-2 receptor complex), growth factor receptors (eg vascular endothelial growth factor receptor, VEGFR), and other signaling receptors play significant roles in understanding cell activation and proliferation.

Intracellular markers

Intracellular markers are molecules located within cells, specifically within the nucleus or cytoplasm. Examples of intracellular markers include:

Cytokines: Interleukins and interferons provide insights into immune responses.
Transcription factors: FoxP3 is used for identifying regulatory T cells.
Signaling molecules: Phosphorylated proteins such as signal transducers and activators of transcription (STAT) (both signaling molecule and transcription factor) or protein kinase B (AKT) are analyzed to study cell signaling pathways.

Intracellular markers are important for investigating cell functions, differentiation, and signaling processes.

Functional markers

Functional markers are used to evaluate cellular functions such as cytokine production, signaling pathways, and immune responses, providing insights into immune mechanisms and their roles in diseases.

These markers are particularly significant in cancer research for identifying immune cell subsets with unique functional profiles. They are also used to evaluate processes such as viability, metabolism, or specific cellular functions. Examples include:

Viability markers: Propidium iodide (PI) or 7- aminoactinomycin D (7-AAD) help distinguish live cells from dead cells.
Calcium flux indicators:Fluo-4 can measure calcium signaling, which is a key aspect of cell activation.
Apoptotic markers: Binding of annexin V can be used to detect phosphatidylserine exposure on the outer membrane of apoptotic cells. Another marker includes caspases that help identify apoptotic cells.

Functional markers are widely used in drug testing, cellular stress studies, and apoptosis assays.

Common flow cytometry CD markers

Flow cytometry CD markers are proteins found on the surface of cells, used to identify and classify different cell types. Common markers include CD3 for T cells, CD19 for B cells, and CD45 for leukocytes. These markers help in studying immune responses, diagnosing diseases, and monitoring treatments.

CD markers for different cell types

CD markers are cell surface proteins or antigens used to identify and differentiate various cell types, stages of development, and activation states in immune cells. These surface proteins play a pivotal role in cellular communication and environmental sensing.

These markers play a key role in immunology, flow cytometry, and cellular research by categorizing cells into specific subpopulations and supporting studies on immune responses, cell development, and disease mechanisms.

CD markers are typically identified by their specific numbering system, such as CD4, CD8, CD34, etc., with each number corresponding to a distinct marker associated with a particular cell type or function.

T cell markers

T cell markers are used to identify the subsets of T cells in flow cytometry. These proteins help in differentiating between naïve, activated, memory or regulated T cells. It also aids in understanding the T cell receptor signaling or understanding any immune response against any disease.

CD3: A universal marker for all T cells and is responsible for immune signaling.
CD4: Expressed on helper T cells (Th cells) and interacts with major histocompatibility complex II (MHC-II).
CD8: Found on cytotoxic T cells (Tc cells) and interacts with MHC-I.
CD25: Expressed on activated T cells or regulatory T cells (Treg cells).
CD45RA and CD62L: Typically expressed on naïve T cells.
CD45RO: Expressed on memory T cells.
Cytotoxic T-lymphocyte-associated protein 4 (CTLA-4): An inhibitory receptor found predominantly in regulatory T cells.
CD28: A co-stimulatory molecule important for T cell activation.

B cell markers

B cell markers are surface proteins that provide insights into various stages of B cell development, including maturation, activation, and differentiation. These markers are essential for distinguishing between different B cell subsets.

By utilizing these markers in flow cytometry, researchers can gain a deeper understanding of immune responses, antibody production, and the roles B cells play in health and disease.

Some of the B cell markers are:

CD19: A universal marker for all B cells, vital for mediating immune responses.
CD20: Found on the surface of mature B cells, used to distinguish B cells from other immune cells.
CD21: A marker for mature B cells used to differentiate between follicular and marginal B cells.
CD23: Expressed on activated B cells and involved in regulating their activation and differentiation.
CD27: Expressed on memory B cells.
CD38: Expressed on plasma cells, employed in flow cytometry to identify plasma cells.
CD40: A co-stimulatory molecule found on B cells.

Myeloid markers

Myeloid markers are surface proteins that are essential for characterizing various myeloid lineage cell types, including neutrophils, eosinophils, basophils, monocytes, and macrophages. These markers enable researchers to study myeloid cell differentiation, their roles in inflammation, and their involvement in various diseases.

Natural killer markers

Natural killer (NK) cells are part of innate immunity. Its marker helps in detecting cell-based activation and differentiation.

CD56: A common marker expressed on natural killer (NK) cells.
NKp46: Involved in the recognition of infected or tumor cells.
CD16: Found on both NK cells and neutrophils.

Monocyte/macrophage markers

Monocytes and macrophages are involved in phagocytosis, antigen presentation, and immune regulation. Their markers help distinguish different subsets and activation states of these cells.

CD11b and CD33: Expressed on monocytes, macrophages and granulocytes.
CD14: Primarily found on monocytes and helps detect bacterial lipopolysaccharides (LPS)
CD68: Expressed on macrophages and promotes phagocytosis.

Dendritic cell markers

Dendritic cells (DCs) are key antigen-presenting cells (APCs) that help in regulating immune responses. Markers specific to dendritic cell markers help in detecting their subtypes. The most important types include:

CD11c: Involved in modulating immune response.
CD80: A co-stimulatory molecule expressed on mature DCs.
CD83: Serves as a maturation marker for DCs.

Flow cytometry CD markers

CD Marker

Cell Type(s)

Function

Applications

CD3

T cells

Marker for T cell lineage involved in TCR signaling

Immune profiling and detection of T cell-related disorder

CD4

Helper T (Th) cells

Expressed on MHC class II and aids in immune response

Diagnosing HIV/AIDS, immune status evaluation

CD8

Cytotoxic T (Tc) cells

Expressed on MHC class I and have cytotoxic activity against infected or tumor cells

Immune profiling, cancer research

CD19

B cells

Markers for B cell lineage and is a part of the B cell receptor complex

Diagnosing B cell leukemias and lymphomas

CD14

Monocytes/macrophages

A part of innate immunity that recognizes bacterial LPS

Studying inflammation, infectious disease research

CD16

Natural killer (NK) cells, macrophages, neutrophils

Mediates antibody-dependent cell cytotoxicity (ADCC)

Cancer immunotherapy research, NK cell profiling

CD25

Regulatory T cells (Tregs), activated T cells

Forms the alpha chain of the IL-2 receptor that regulates immune response

Autoimmune disease research, Treg function analysis

CD34

Hematopoietic stem cells

Marker for stem and progenitor cells that aid in hematopoiesis

Stem cell research, leukemia diagnostics

CD56

NK cells

Marker for NK cells that are associated with cytotoxicity

Immune profiling in infectious diseases and cancer

CD45

All leukocytes

Common leukocyte antigen that is vital for immune cell signaling

Differentiating leukocytes, studying hematologic disorders

Activation and differentiation markers

Activation and differentiation markers are used to study the functional state and lineage commitment of cells. These markers help identify cellular responses to stimuli and trace developmental pathways in various biological and clinical contexts.

Key activation markers

Activation markers like human leukocyte antigen – DR isotype (HLA-DR), CD69, CD25, CD71, and CD40L are indicative of T cell activation. They are important in diagnosing conditions such as hypomorphic severe combined immunodeficiency (SCID) and maternal engraftment. Monitoring these markers is vital for follow-up assessments required when a newborn screening test identifies potential T cell deficiencies. Many cell surface makers are upregulated upon T cell activation at different stages of the activation process. A few such markers are summarized below:

Early-stage T cell activation markers

CD25: This is upregulated following T cell activation. It is associated with interleukin 2 (IL-2) and is involved in T cell proliferation.
CD69: It is expressed following T cell activation.

Late-stage T cell activation markers

HLA-DR: An MHC class II molecule, upregulated during T cell activation for antigen presentation.
CD40L (CD154): The interaction of this marker with CD40 is vital in the priming of CD4+ T cells by dendritic cells, among other functions.

Differentiation markers for T cells

Differentiation markers help distinguish between distinct subsets of T cells, highlighting their unique roles and characteristics.

CD45RA/RO: These markers are helpful in distinguishing between naïve T cells and memory T cells, marked by CD45RA and CD45RO, respectively.
FoxP3: It is expressed on Treg cells, aiding in their differentiation from other T cell types.
CD127: This marker is a part of the interleukin -7 receptor, expressed on immune cells. It helps in monitoring human immunodeficiency virus (HIV) antiviral therapy. It also inversely co-relates with FoxP3, distinguishing Treg cells.

Flow cytometry markers are used to identify and analyze specific cellular characteristics related to diseases. These markers help in diagnosing, monitoring, and understanding various medical conditions. By targeting disease-specific markers, this technique enables precise and rapid detection of abnormalities at the cellular level.

Leukemia and lymphoma markers

Leukemia and lymphoma markers are substances produced either by cancer cells or by the body in response to cancer. These markers provide valuable information about the aggressiveness of the disease, potential treatment options, or the patient’s response to therapy.

Tumor marker tests are commonly used for diagnosing cancer, guiding treatment, and monitoring progress, with new markers frequently emerging. While some markers serve as therapeutic targets across multiple cancers, their role as diagnostic markers is often specific to certain cancer types.

Key markers include:

CD19 and CD20: Commonly used for identifying B cell malignancies.
CD3, CD4, and CD8: Used for diagnosing T cellmalignancies.
CD34: Primarily used in acute leukemias.
Additional markers: CD5, CD10, CD23, CD30, and light chains (kappa and lambda) assist in diagnosing specific subtypes of leukemia and lymphoma, as well as assessing clonality.

Minimal residual disease (MRD) studies often use flow cytometry to identify leukemic cells based on their unique immunophenotypic signatures, distinguishing them from normal bone marrow cells.

Standard 4-color flow cytometry can detect as few as one leukemic cell among 10,000 normal cells, though this requires significant expertise. Advancements in identifying new and easily detectable leukemia markers could simplify MRD studies, improve accessibility for more patients, and enhance detection sensitivity.

Autoimmune disease and HIV progression markers

Autoimmune diseases: Autoimmunity is triggered in the body when the immune system mistakenly attacks healthy cells. The markers for autoimmunity in flow cytometry can help in detecting the dysregulation of immune cells in these conditions.

CD19 and CD20: These markers can indicate B cell alterations in autoimmune diseases such as systemic lupus erythematosus (SLE).
CD4/CD8 ratio: This ratio is used to assess T cell imbalances in conditions like rheumatoid arthritis (RA).
HLA-DR: Expressed on immune cells, signals increased activation in autoimmune disorders. It influences macrophage activation, leading to the polarization of pro-inflammatory (M1) or anti-inflammatory (M2) macrophages.

These markers help detect autoimmune diseases, track their progression, and evaluate the effectiveness of treatments.

HIV progression: HIV infection primarily attacks the CD4+ or helper T cells, leading to the weakening of the immune system. Several markers help in tracking disease progression.

CD4+ T cell count: A vital marker for evaluating immune health and staging HIV progression.
CD8+ T cell activation: Measured using markers such as HLA-DR and CD38, which reflect the immune response to HIV.
PD-1 and CTLA-4: These markers indicate T cell exhaustion, with PD-1 expressed on CD4+ and CD8+ T cells and CTLA-4 upregulated on exhausted CD4+ T cells. This correlates with disease progression and T cell dysfunction.
Ki-67: A marker of immune cell proliferation, often elevated during active viral replication.

Cancer stem cell markers

Cancer stem cells (CSCs) are a small subset of tumor cells with self-renewal, differentiation, and tumor-forming abilities. MicroRNAs and signaling pathways, such as Wnt/β-catenin, Notch, and Hedgehog, regulate these.

CD44, CD24, and CD133: These markers help identify CSCs, which are resistant to conventional therapies and play a key role in cancer metastasis.

Targeting CSCs holds promise for developing novel cancer treatments, with ongoing research focusing on miRNA and epithelial-mesenchymal transition (EMT) to improve clinical outcomes.

Marker combinations for clinical applications

Leukemia and lymphoma markers

Key markers include:

CD19 and CD20: Commonly used for identifying B cell malignancies.
CD3, CD4, and CD8: Used for diagnosing T cell malignancies.
CD34: Primarily used in acute leukemias.
Additional markers: CD5, CD10, CD23, CD30, and light chains (kappa and lambda) assist in diagnosing specific subtypes of leukemia and lymphoma, as well as assessing clonality.

Minimal residual disease (MRD) studies often use flow cytometry to identify leukemic cells based on their unique immunophenotypic signatures, distinguishing them from normal bone marrow cells.

Autoimmune disease and HIV progression markers

CD19 and CD20: These markers can indicate B cell alterations in autoimmune diseases such as systemic lupus erythematosus (SLE).
CD4/CD8 ratio: This ratio is used to assess T cell imbalances in conditions like rheumatoid arthritis (RA).
HLA-DR: Expressed on immune cells, signals increased activation in autoimmune disorders. It influences macrophage activation, leading to the polarization of pro-inflammatory (M1) or anti-inflammatory (M2) macrophages.

These markers help detect autoimmune diseases, track their progression, and evaluate the effectiveness of treatments.

HIV progression: HIV infection primarily attacks the CD4+ or helper T cells, leading to the weakening of the immune system. Several markers help in tracking disease progression.

CD4+ T cell count: A vital marker for evaluating immune health and staging HIV progression.
CD8+ T cell activation: Measured using markers such as HLA-DR and CD38, which reflect the immune response to HIV.
PD-1 and CTLA-4: These markers indicate T cell exhaustion, with PD-1 expressed on CD4+ and CD8+ T cells and CTLA-4 upregulated on exhausted CD4+ T cells. This correlates with disease progression and T cell dysfunction.
Ki-67: A marker of immune cell proliferation, often elevated during active viral replication.

Cancer stem cell markers

CD44, CD24, and CD133: These markers help identify CSCs, which are resistant to conventional therapies and play a key role in cancer metastasis.

Targeting CSCs holds promise for developing novel cancer treatments, with ongoing research focusing on miRNA and epithelial-mesenchymal transition (EMT) to improve clinical outcomes.

Innovations and advances in flow cytometry markers

Innovations in flow cytometry markers have enhanced the precision and efficiency of cellular analysis. Advances such as multi-color markers and high-throughput capabilities allow for detailed profiling of complex cell populations.

These developments contribute significantly to disease diagnosis, therapeutic monitoring, and cutting-edge research in immunology and oncology.

Emerging technologies in flow cytometry

Emerging technologies in flow cytometry have improved the accurate evaluation of cell samples, enabling more precise identification and prediction of cell surface markers.

Spectral flow cytometry

Spectral flow cytometry allows high-dimensional, high-throughput analysis of large cohorts of single cells, enabling comprehensive immunophenotyping of human peripheral blood and bone marrow. It includes two antibody panels for blood and one for bone marrow, which assesses numerous cell surface markers, phenotypes, and cellular states, including exhaustion, activation, and differentiation.

Mass cytometry (CyTOF)

Mass cytometry, also termed cytometry by time-of-flight (CyTOF), has transformed immunophenotyping by enabling detailed, simultaneous analysis of immune populations with minimal samples, particularly in tumor immunotherapy settings.

It facilitates robust analysis of up to 60 parameters by replacing fluorescent labels with metal isotopes, though this comes with increased complexity in experiment design and data interpretation. These challenges can be resolved by following a comprehensive resource guide for experiment design, antibody conjugation, sample staining, and data analysis, with comparisons of different methods to streamline workflows for both beginners and advanced users.

Imaging flow cytometry

Imaging flow cytometry merges the high-event rate of flow cytometry with the single-cell image acquisition of microscopy, enabling the measurement of numerous features from resulting images for rich data sets.

This primer covers typical imaging flow instrumentation, data acquisition, and analysis tools, aiding in the evolution of analysis methods, from basic image features and gating strategies to advanced machine learning and deep learning techniques for phenotype classification.

Trends in flow cytometry markers

Automated flow cytometry data analysis tools are gaining traction in academic, biotechnology, pharmaceutical, and clinical laboratories, aiming to improve reproducibility and overcome bottlenecks in manual gating.

However, most clinical laboratories still need to adopt automated methods, with data output quality being the most important factor for those that have. Additionally, usage patterns vary between academic and clinical settings.

Best practices for using flow cytometry markers

Flow cytometry is an effective method for analyzing cell populations based on physical and molecular characteristics, requiring careful selection and use of appropriate markers for accurate results. Best practices for choosing and optimizing flow cytometry markers are essential to ensure reproducibility and reliability.

Choosing the right markers

When selecting markers for flow cytometry, it is recommended to choose those based on the biological questions you aim to answer and ensure they are well-validated for the target cells. The focus should be on markers with high specificity and sensitivity to reduce off-target binding and enhance detection.

Designing the panel carefully, selecting compatible fluorophores, and validating the markers through pilot experiments, using proper controls help to assess their performance and non-specific binding.

Marker compensation and optimization

Marker compensation and optimization in flow cytometry involves:

Using single-stained controls to address fluorescence spillover for accurate compensation and titrating antibodies to avoid non-specific binding or signal saturation.
Proper use of fixatives is essential to preserve fluorophore integrity and marker epitopes, especially for intracellular staining.
Following standardized staining protocols and incorporating blocking reagents helps reduce background noise and ensures reliable results.

Common challenges in flow cytometry

Flow cytometry faces challenges like spectral overlap, where fluorescence spillover affects adjacent channels, which can be mitigated by using well-designed panels and proper compensation.

Other issues, such as non-specific antibody binding, dead cell interference, and poor sample quality, can lead to false-positive results and skewed data. These challenges can be addressed using isotype controls, viability dyes, and proper sample preparation. Instrument variability may also cause inconsistencies, which can be managed through regular calibration and the use of reference standards.

FAQs

What are the most used CD markers in flow cytometry?

The most commonly used CD markers in flow cytometry include CD3 for T cells, CD19 for B cells, and CD45 as a pan-leukocyte marker. Other frequently used markers are CD4 and CD8 for differentiating T-helper and cytotoxic T cells, respectively, and CD14 for monocytes. These markers are vital for identifying and characterizing immune cell subsets in research and clinical diagnostics.

How do you differentiate between T cell and B cell markers in flow cytometry?

T cell markers include CD3, a definitive marker for all T cells, and CD4 or CD8, which distinguish between T-helper and cytotoxic T cells, respectively. B cell markers, such as CD19 and CD20, are specific to B lymphocytes and help in identifying and studying this subset. In flow cytometry, these cell types are differentiated by tagging them with fluorescently labeled antibodies specific to these markers, allowing precise detection and analysis.

What are the key markers for identifying myeloid cells in flow cytometry?

Key markers for identifying myeloid cells in flow cytometry include CD11b and CD33, which are broadly expressed across myeloid lineages. CD14 is commonly used for monocytes, while CD15 helps identify granulocytes, such as neutrophils. Additional markers like CD64 and HLA-DR can be used to refine the characterization of specific myeloid cell subtypes.

Flow cytometry solutions

In research and clinical settings, flow cytometry is widely used for immunophenotyping, assessing the cellular composition of samples, evaluating cellular function and health, isolating selected cells by sorting, and in biomarker and drug discovery.

Explore our curated catalog of conjugated and carrier-free antibodies, conjugation and assay kits, and more, to find solutions to support your research.

Browse

button-primary